Diving deeper into Orphan Diseases – Marfan Syndrome (Part 2)
At Elastrin, there‘s something new every day.
Elastin Fiber antibodies guide the therapy to where it needs to be
- Jan 14
- 2 min
Diving deeper into Orphan Diseases - Marfan Syndrome - Part 1
- Dec 23, 2023
- 1 min
Elastrin Therapeutics DESTiNED Technology: A Nanoparticle Revolution
- Dec 15, 2023
- 2 min
Chronic Obstructive Pulmonary Disease (COPD) / Lung Emphysema - Part 2
- Nov 20, 2023
- 4 min
Chronic Obstructive Pulmonary Disease (COPD) / Lung Emphysema - Part 1
- Oct 24, 2023
- 2 min
New review: Role of elastic fiber degradation in disease pathogenesis
- Jul 23, 2023
- 4 min
Synthetic mRNA Therapies in Rare Diseases
- Mar 26, 2023
- 5 min
Diving deeper into orphan diseases - Williams-Beuren Syndrome (WBS)
- Jan 23, 2023
- 3 min
Diving deeper into orphan diseases - Generalized arterial calcification of infancy
- Dec 6, 2022
- 3 min
Diving deeper into orphan diseases - Pseudoxanthoma elasticum
- Nov 7, 2022
- 1 min
Using synthetic mRNA coding for Tropoelastin (TE) mRNA
- Aug 22, 2022
- 2 min
An insight into orphan diseases and why research into those rare diseases matters!
- Apr 7, 2022
- 3 min
Kizoo Portfolio Company Elastrin Therapeutics Inc. closes $10M Funding Round
- Feb 14, 2022
- 2 min
Regenerative Medicine – Part 2
- Feb 9, 2022
- 1 min
Interview with the SC Business Review
- Jan 18, 2022
- 4 min
Elastrin Therapeutics Announces Newly Formed Scientific Advisory Board
- Jan 4, 2022
- 2 min
Regenerative Medicine - Part 1
- Dec 19, 2021
- 2 min
The World’s Deadliest Killer: The Heart
- Nov 18, 2021
- 1 min
Winner @ InnoVision Awards 2021
- Mar 5, 2021
- 3 min
Elastrin Therapeutics Inc. Closes Seed Funding Round with Kizoo Technology Capital